Patents, Profiles, Patience, and the Power of a Good “No”: The Panaceutics Rx Story

15 Apr

By Rory McCann, Marketing Manager & Conference Producer, LSN

Panaceutics Rx is an early-stage company advancing accessible personalized medicine based on patients’ digital health profiles using robotic platforms and patented processes.

We spoke with Panaceutics CEO, Edison Hudson about the need for more accessible adherence to life-saving therapies and Panaceutics’ approach to working with hospitals, investors, and physicians.

Panaceutics Rx is an Innovator’s Pitch Challenge winner at last month’s Longevity, Health & Innovation, a Redefining Early Stage Investments (RESI) partnering event. Learn more about RESI and sign up by May 7 to save $50 on early bird rates.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: